British Journal of Cancer
Journal Abbreviation: BRIT J CANCER
ISSN: 0007-0920
Publisher: Cancer Research UK
Publications (45)
Reply: Intra-patient heterogeneity of BRAF mutation status: fact or fiction? (2014)
Heinzerling L, Schuler G, Hartmann A, Schneider-Stock R
Journal article, Letter
Multi-colour FISH in oesophageal adenocarcinoma-predictors of prognosis independent of stage and grade (2014)
Geppert CI, Ruemmele P, Sarbia M, Langer R, Feith M, Morrison L, Pestova E, et al.
Journal article
Evidence for a time-dependent association between FOLR1 expression and survival from ovarian carcinoma: implications for clinical testing. An Ovarian Tumour Tissue Analysis consortium study (2014)
Koebel M, Madore J, Ramus SJ, Clarke BA, Pharoah PDP, Deen S, Bowtell DD, et al.
Journal article
FGF receptor genes and breast cancer susceptibility: results from the Breast Cancer Association Consortium (2014)
Agarwal D, Pineda S, Michailidou K, Herranz J, Pita G, Moreno LT, Alonso MR, et al.
Journal article
Molecular staging of lymph node-negative colon carcinomas by one-step nucleic acid amplification (OSNA) results in upstaging of a quarter of patients in a prospective, European, multicentre study (2014)
Croner RS, Geppert CI, Bader FG, Nitsche U, Spaeth C, Rosenberg R, Zettl A, et al.
Journal article
Strong reduction of AGO2 expression in melanoma and cellular consequences (2013)
Voeller D, Reinders J, Meister G, Bosserhoff AK
Journal article
Presence of the Coxsackievirus and Adenovirus Receptor (CAR) in human neoplasms: A multitumour array analysis (2013)
Reeh M, Bockhorn M, Görgens D, Vieth M, Hoffmann T, Simon R, Izbicki JR, et al.
Journal article
Impact of peritoneal carcinomatosis in the disease history of colorectal cancer management: A longitudinal experience of 2406 patients over two decades (2013)
Kerscher AG, Chua TC, Gasser M, Maeder U, Kunzmann V, Isbert C, Germer CT, Pelz JO
Journal article
Protumoral roles of melanoma inhibitory activity 2 in oral squamous cell carcinoma (2013)
Kurihara M, Kirita T, Sasahira T, Ohmori H, Matsushima S, Yamamoto K, Kuniyasu H, Bosserhoff AK
Journal article
MiR-210 is a target of hypoxia-inducible factors 1 and 2 in renal cancer, regulates ISCU and correlates with good prognosis (2013)
McCormick RI, Blick C, Ragoussis J, Schödel J, Mole DR, Young AC, Selby PJ, et al.
Journal article